Delivery Order SPE2DB22D2006-SPE2DB23FW2ZH
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of VENOFER 100 MG/5 ML VIAL 5ML, a pharmaceutical product. The award is a delivery order with a firm fixed price of $1,022.90 and an ultimate completion date of January 29, 2025. This contract award is not designated with a set-aside requirement. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role...
- This federal contract award is for the delivery of VENOFER 100 MG/5 ML VIAL 5ML to the Defense Logistics Agency, a defense agency. The contract has a ceiling value of $6,407.87 and is a firm fixed price delivery order with a completion date of June 13, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside and was awarded on June 12, 2025. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award is for the delivery of VENOFER 100 MG/5 ML VIAL 5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,902.52 and is a firm fixed-price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,835.96 firm fixed-price contract is for the supply of VENOFER 100 MG/5 ML VIAL 5ML, a pharmaceutical product. The contract has an ultimate completion date of January 25, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,111.11, is for the delivery of VENOFER 100 MG/5 ML VIAL 5ML, a medical product. The contract has an ultimate completion date of January 10, 2024 and is structured as a Firm Fixed Price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,409.96, is a Firm Fixed Price Delivery Order for the provision of VENOFER 100 MG/5 ML VIAL 5ML medical supplies. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which...
- This federal contract award is for the delivery of the pharmaceutical product Venofer 100 mg/5 ml vial, 5 ml, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract has a ceiling value of $1,858.84 and a completion date of May 30, 2025. The contract is a Firm Fixed Price Delivery Order and is not set aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical supplier...
- This federal contract award is for the delivery of Venofer 100 mg/5 ml vials, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award has a ceiling value of $3,553.46 and an ultimate completion date of December 22, 2023. It is a delivery order contract with a firm fixed price pricing type. The contract is not designated with a set-aside....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Venofer 200 mg/10 ml vials. The contract has a ceiling value of $2,555.60 and a performance period ending on May 6, 2025. This award is not set-aside and is a firm fixed-price contract. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- This federal contract award is for the delivery of Venofer 100 mg/5 ml vials (5 ml) to the Defense Logistics Agency (DLA). The $3,751.29 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB23FW2ZHDelivery Order
This federal contract award, with the ID SPE2DB22D2006|SPE2DB23FW2ZH, was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of VENOFER 100 MG/5 ML VIAL 5ML, a pharmaceutical product, with a ceiling value of $5,151.27. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 20, 2023. This award is not associated with a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 9/19/23 |